Reframe Cancer
PrivateCompany Overview
Reframe Cancer is a healthcare services company that provides personalized clinical navigation and support for individuals diagnosed with cancer and their carers.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, InsurTech, Telemedicine, HR
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reframe Cancer Comparables
Compare Reframe Cancer with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Check4Cancer | 89% | |
| Perci Health | 85% | |
| Jasper Health | 78% | |
Reframe Cancer Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 31% MoM, from 3K to 4K.
- May 2, 2025
Monthly visitors grew 186% MoM, reaching 4K.
Reframe Cancer Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reframe Cancer's valuation, stock price, and market status.